Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

The specific antigen approach in multiple sclerosis: Can it ever be enough?
Long-term treatment risks in multiple sclerosis: risk knowledge and risk perception in a large cohort of mitoxantrone-treated patients.
Atorvastatin Added to Interferon Beta for Relapsing Multiple Sclerosis: 12-Month Treatment Extension of the Randomized Multicenter SWABIMS Trial.
Reliability and Validity of PROMIS Cognitive Abilities and Cognitive Concerns Scales Among People with Multiple Sclerosis.
Autoantibody biomarkers in childhood-acquired demyelinating syndromes: results from a national surveillance cohort.
Opexa Therapeutics provides MS trial enrollment update; 70% of patients enrolled
Use and acceptance of electronic communication by patients with multiple sclerosis: a multicenter questionnaire study.
Segmentation of magnetization transfer ratio lesions for longitudinal analysis of demyelination and remyelination in multiple sclerosis.
Multiple sclerosis: Infertility treatment increases multiple sclerosis activity.
Imatinib ameliorates neuroinflammation in a rat model of multiple sclerosis by enhancing blood-brain barrier integrity and by modulating the peripheral immune response.
Drainage of Cells and Soluble Antigen from the CNS to Regional Lymph Nodes.
T Cell Mediated Pathogenesis in EAE: Molecular Mechanisms.
Severe Autoimmune Adverse Events Post Herpes Zoster Vaccine: A Case-Control Study of Adverse Events in a National Database.
[Retrospective study of clinical features of neuromyelitis optica spectrum disease with connective tissue disease].
Multimodal Quantitative MR Imaging of the Thalamus in Multiple Sclerosis and Neuromyelitis Optica.
The Incidence, Prevalence, Costs and Impact on Disability of Common Conditions Requiring Rehabilitation in the US: Stroke, Spinal Cord Injury, Traumatic Brain Injury, Multiple Sclerosis, Osteoarthritis, Rheumatoid Arthritis, Limb Loss, and Back Pain.
Disease activity and disability evolution under glatiramer acetate: A clinical approach.
Self-intermittent catheterization in multiple sclerosis.
Multiple sclerosis: KIR4.1 as an autoantigen in MS-new questions raised.
Potential disease-modifying effects of selective serotonin reuptake inhibitors in multiple sclerosis: systematic review and meta-analysis.
Blood coagulation protein fibrinogen promotes autoimmunity and demyelination via chemokine release and antigen presentation.
Exercise in the community for people with minimal gait impairment due to MS: an assessor-blind randomized controlled trial.
Leuprolide Acetate, a GnRH Agonist, Improves Experimental Autoimmune Encephalomyelitis: A Possible Therapy for Multiple Sclerosis.
[Expression of human B-cell specific receptor FCRL1 in normal individuals and in patients with autoimmune diseases].
Is metabolic flexibility altered in multiple sclerosis patients?

Pages